Archives of Gynecology and Obstetrics

, Volume 252, Issue 1, pp 49–53

Influence on erythropoietin levels of treatment with cisplatinum-endoxan

  • W. Lechner
  • E. Artner-Dworzak
  • E. Sölder
  • M. Sachsenmaier
  • D. Kölle
  • H. Moncayo
  • R. Reitsamer
Originals

Summary

Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.

Key words

Erythropoietin Cytostatic agents Cisplatinum Endoxan 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E (1987) Stimulation of fetal hemoglobin synthesis by Erythropoietin. N Engl J Med 317:415PubMedGoogle Scholar
  2. 2.
    Bray GL, Reaman GH (1988) Partial deficiency of erythropoietin (EPO) resulting from cisplatin (CPDD) mediated nephrotoxicity. Blood 72 (Suppl): 37aGoogle Scholar
  3. 3.
    Carnot P, Deflandre C (1906) Sur l'activité hémopoietique des differents organes au cours de la régéneration du sang. Comptes rendues hebd. des Séances de l'Acad Sci Paris 143:432Google Scholar
  4. 4.
    Erslev AJ (1953) Humoral regulation of red cell production. Blood 8:349PubMedGoogle Scholar
  5. 5.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human Erythropoietin. Results of a Combined Phase I and II Clinical Trial. N Engl J Med 316:73PubMedGoogle Scholar
  6. 6.
    Fischl M, Galpin JE, Levine JD et al. (1990) Recombinant human Erythropoietin for patients with aids treated with zidovudine. N Engl J Med 322:1488PubMedGoogle Scholar
  7. 7.
    Hashimi LA, Khalyl MF, Salem PA (1984) Supraventricular tachycardia. A probable complication of platinum treatment. Oncology 41:174PubMedGoogle Scholar
  8. 8.
    Jacobs K, Shoemaker C, Rudersdorf F et al. (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313:806CrossRefPubMedGoogle Scholar
  9. 9.
    Jacobson LO, Goldwasser E, Fried W, Placak IF (1957) The role of kidney in erythropoiesis. Nature 179:633PubMedGoogle Scholar
  10. 10.
    Ludwig H, Fritz E, Kotzmann H et al. (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1693PubMedGoogle Scholar
  11. 11.
    Miller CB, Jones RJ, Pantadosi S et al. (1989) Decreased erythropoietin (EPO) response associated with the anemia of malignancy. Paper presented at American Society of Clinical Oncology Annual Meeting. San Francisco, CA: 1989 May 23Google Scholar
  12. 12.
    Miyake T, Kung CK-H, Goldwasser E (1977) Purification of human erythropoietin. J Biol Chem 252:558Google Scholar
  13. 13.
    Reissmann KR (1950) Studies on the mechanism of erythropoietin stimulation in parabiotic rats during hypoxia. Blood 5:372PubMedGoogle Scholar
  14. 14.
    Wieczorek L, Hirth P, Schöpe KB, Scigalla P, Kruger D (1989) Molekulare Biologie von Erythropoietin: Innovative Aspekte der klinischen Medizin. Springer, Berlin Heidelberg New YorkGoogle Scholar
  15. 15.
    Winearls CG, Oliver DO, Pippard MJ et al. (1986) Effect of human Erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet II:1175Google Scholar
  16. 16.
    Wood P, Nygaard S, Hrhushesky WJM (1988) Cisplatin-induced anemia is correctable with erythropoietin. Blood 72 (Suppl): 52aGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • W. Lechner
    • 1
  • E. Artner-Dworzak
    • 2
  • E. Sölder
    • 1
  • M. Sachsenmaier
    • 1
  • D. Kölle
    • 1
  • H. Moncayo
    • 1
  • R. Reitsamer
    • 1
  1. 1.Department of Obstetrics and GynecologyUniversity of InnsbruckInnsbruckAustria
  2. 2.Institute of Medical ChemistryUniversity of InnsbruckInnsbruckAustria
  3. 3.Universitätsklinik für FrauenheilkundeInnsbruckAustria

Personalised recommendations